Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
PCCYTOV
Stock Latest News
Private Companies
Cytovale Deepens Sepsis Focus With Outcomes Data and SEP-1-Aligned Strategy
2d ago
CYTOV
Premium
Private Companies
Cytovale Showcases Rapid Sepsis Testing and Outcomes Data at SCCM 2026
3d ago
CYTOV
Premium
Private Companies
Cytovale Highlights Rapid Sepsis Testing Data Ahead of SCCM 2026
4d ago
CYTOV
Premium
Private Companies
Cytovale Aligns Sepsis Strategy With Evolving SEP-1 Quality and Reimbursement Pressures
7d ago
CYTOV
Premium
Private Companies
Cytovale Leverages Sepsis Outcomes and SEP-1 Pressures to Deepen ED Footprint
9d ago
CYTOV
Premium
Private Companies
Cytovale Highlights Emergency Department Triage and Patient Safety Focus
13d ago
CYTOV
Premium
Private Companies
Cytovale Emphasizes Triage Risk Assessment and Patient Safety in Emergency Care
14d ago
CYTOV
Premium
Private Companies
Cytovale Leverages Outcome Data and SEP-1 Pressures to Advance IntelliSep Sepsis Tool
16d ago
CYTOV
Premium
Private Companies
Webinar Spotlight Puts Financial Focus on Sepsis Performance and Hospital Throughput
16d ago
CYTOV
Premium
Private Companies
Cytovale Highlights Financial Impact of SEP-1 Sepsis Performance and ED Decision-Making
17d ago
CYTOV
Premium
Private Companies
Cytovale Highlights Workflow-Integrated Sepsis Risk Tool for Emergency Departments
18d ago
CYTOV
Premium
Private Companies
Cytovale Emphasizes Integrated Sepsis Workflow Support in Emergency Departments
19d ago
CYTOV
Premium
Private Companies
Sepsis Diagnostic IntelliSep Linked to Improved Outcomes at Froedtert Hospital
20d ago
CYTOV
Premium
Private Companies
Sepsis Diagnostic Tool IntelliSep Highlighted in Real-World Hospital Outcome Data
21d ago
CYTOV
Premium
Private Companies
Cytovale – Weekly Recap
23d ago
CYTOV
Premium
Private Companies
Webinar Underscores Clinical Use of Cytovale’s IntelliSep Sepsis Diagnostic
23d ago
CYTOV
Premium
Private Companies
Webinar Showcases IntelliSep Use in Emergency Department Sepsis Triage
24d ago
CYTOV
Premium
Private Companies
Cytovale Highlights Evolving Sepsis Strategies Amid Value-Based Purchasing Focus
25d ago
CYTOV
Premium
Private Companies
Cytovale Highlights Financial and Operational Stakes in Evolving Sepsis Management
25d ago
CYTOV
Premium
Private Companies
Sepsis Strategy and SEP-1 Performance Draw Focus in Hospital Finance Discussion
25d ago
CYTOV
Premium
Private Companies
Evolving Sepsis Strategies Highlight Demand for Risk Assessment Tools
26d ago
CYTOV
Premium
Private Companies
Clinical Outcome Data Suggest Potential Impact of Cytovale’s IntelliSep on Sepsis Mortality
26d ago
CYTOV
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.